{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:03Z","timestamp":1791389883187,"version":"4.3.3"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The objective of this study is to determine the drug resistance status of pulmonary tuberculosis patients in Jilin Province.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A retrospective survey was conducted on 395 sputum culture TB-positive patients admitted to the tuberculosis hospital in Jilin Province in 2019. Sputum samples were cultured in acidic Roche medium. Drug sensitivity testing was conducted using the proportional method. Sensitivity was reported if the percentage of drug resistance was less than 1%, and resistance was reported if the percentage was \u22651%. Statistical analysis was performed using SPSS 22.0.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> 395 tuberculosis patients with positive sputum tuberculosis culture were included in the study, with 102 being initially treated and 293 being retreated. The study population consisted of 283 males and 112 females. Sex, age, nationality, occupation, marital status, diabetes comorbidity, initial treatment, normal health status, BCG vaccine vaccination, smoking, and alcohol consumption were considered as factors that may affect the rate of multidrug resistance. And only the history of treatment (initial treatment) was associated with multidrug resistance (<jats:italic>p<\/jats:italic> = 0.032). This indicates that retreatment is the most significant risk factor for the occurrence of multidrug resistance in tuberculosis. The multidrug resistance rate in retreated patients is 3.764 times higher than that in initially treated patients.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The prevalence of multidrug-resistant is higher in retreated patients compared to initially treated patients in the study population. Multidrug resistance is only associated with the treatment history (initial retreatment) and not with other factors.<\/jats:p>","DOI":"10.3389\/fphar.2023.1263726","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T01:36:27Z","timestamp":1695692187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China"],"prefix":"10.3389","volume":"14","author":[{"given":"Li","family":"Sichen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Youbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Hongfei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"B1","article-title":"Tuberculosis","volume-title":"StatPearls","author":"Adigun","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.5588\/ijtld.21.0664","article-title":"The economic burden of TB faced by patients and affected families in Papua New Guinea","volume":"26","author":"Aia","year":"2022","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.tube.2021.102091","article-title":"Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis","volume":"129","author":"Alame Emane","year":"2021","journal-title":"Mycobacterium Tuberc. Tuberc. (Edinb)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/antibiotics8030090","article-title":"Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan","volume":"8","author":"Ali","year":"2019","journal-title":"Antibiot. (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.medcle.2021.04.006","article-title":"Diabetes and tuberculosis: A syndemic complicated by COVID-19","volume":"157","author":"Antonio-Arques","year":"2021","journal-title":"Med. Clin. Barc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global tuberculosis report 2020 - reflections on the global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ijid.2022.03.011","article-title":"The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB","volume":"124","author":"Chakaya","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3760\/cma.j.cn112147-20221222-00986","article-title":"Expert consensus on surgical treatment of multidrug-resistant and rifampicin-resistant pulmonary tuberculosis in China","volume":"46","year":"2023","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ajic.2022.01.021","article-title":"Prevalence and incidence of tuberculosis in health workers: A systematic review of the literature","volume":"50","author":"da Silva","year":"2022","journal-title":"Am. J. Infect. Control"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.5588\/ijtld.22.0091","article-title":"The household economic burden of drug-susceptible TB diagnosis and treatment in the Gambia","volume":"26","author":"Devoid","year":"2022","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0148041","DOI":"10.1371\/journal.pone.0148041","article-title":"The prevalence of drug-resistant tuberculosis in mainland China: An updated systematic review and meta-analysis","volume":"11","author":"Duan","year":"2016","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/tri.12913","article-title":"Transplant size mismatch in restrictive lung disease","volume":"30","author":"Ganapathi","year":"2017","journal-title":"Transpl. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12879-017-2882-y","article-title":"Do retreatment tuberculosis patients need special treatment response follow-up beyond the standard regimen? Finding of five-year retrospective study in pastoralist setting","volume":"17","author":"Getnet","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e109563","DOI":"10.1371\/journal.pone.0109563","article-title":"Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India","volume":"9","author":"Goswami","year":"2014","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/inthealth\/ihac039","article-title":"Continuous surveillance of drug-resistant TB burden in Rwanda: A retrospective cross-sectional study","volume":"15","author":"Habimana-Mucyo","year":"2023","journal-title":"Int. Health"},{"key":"B18","volume-title":"Major infectious diseases","author":"Holmes","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/tmi.13205","article-title":"Low prevalence of MDR-TB in Lao PDR: Results from the first national anti-tuberculosis drug resistance survey","volume":"24","author":"Iem","year":"2019","journal-title":"Trop. Med. Int. Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.1016\/j.ijtb.2022.10.017","article-title":"Challenges of diabetes in elderly TB patients","volume":"69","author":"Jali","year":"2022","journal-title":"Indian J. Tuberc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0001205","DOI":"10.1371\/journal.pgph.0001205","article-title":"Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries","volume":"2","author":"Jarde","year":"2022","journal-title":"PLOS Glob. Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40249-021-00811-w","article-title":"Implementing a new tuberculosis surveillance system in zhejiang, Jilin and ningxia: Improvements, challenges and implications for China's national health information system","volume":"10","author":"Jiang","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"B23","article-title":"Active tuberculosis","volume-title":"StatPearls","author":"Jilani","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijtb.2019.11.003","article-title":"Protocol for the management of newly diagnosed cases of tuberculosis","volume":"66","author":"Katiyar","year":"2019","journal-title":"Indian J. Tuberc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/IDR.S335329","article-title":"Predictors and trends of MDR\/RR-TB in shenzhen China: A retrospective 2012-2020 period analysis","volume":"14","author":"Lecai","year":"2021","journal-title":"Infect. Drug Resist"},{"key":"B26","doi-asserted-by":"publisher","first-page":"935080","DOI":"10.3389\/fmed.2022.935080","article-title":"The application of artificial intelligence in the diagnosis and drug resistance prediction of pulmonary tuberculosis","volume":"9","author":"Liang","year":"2022","journal-title":"Front. Med. (Lausanne)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"943545","DOI":"10.3389\/fcimb.2022.943545","article-title":"Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management","volume":"12","author":"Liebenberg","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/ijerph17041400","article-title":"A new financing model for tuberculosis (TB) care in China: Challenges of policy development and lessons learned from the implementation","volume":"17","author":"Long","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.33073\/pjm-2022-018","article-title":"Prevalence and drug resistance pattern of Mycobacterium tuberculosis isolated from tuberculosis patients in Basra, Iraq","volume":"71","author":"Mohammed","year":"2022","journal-title":"Pol. J. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2174\/1389201021666200226100242","article-title":"Prevalence of multi-drug resistant tuberculosis among tuberculosis patients attending chest clinics in osun-state, Nigeria","volume":"21","author":"Oyedeji","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"190035","DOI":"10.1183\/16000617.0035-2019","article-title":"Regimens to treat multidrug-resistant tuberculosis: Past, present and future perspectives","volume":"28","author":"Pontali","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/tropicalmed7100300","article-title":"Mycobacterium tuberculosis drug resistance in Ethiopia: An updated systematic review and meta-analysis","volume":"7","author":"Reta","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"210264","DOI":"10.1183\/16000617.0264-2021","article-title":"COVID-19 and tuberculosis: The double whammy of respiratory pathogens","volume":"31","author":"Shariq","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e5541","DOI":"10.7759\/cureus.5541","article-title":"Determinants of drug resistance in previously-treated pulmonary tuberculosis patients registered at a chest clinic in south Delhi, India","volume":"11","author":"Sharma","year":"2019","journal-title":"Cureus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0229040","DOI":"10.1371\/journal.pone.0229040","article-title":"The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia","volume":"15","author":"Shibabaw","year":"2020","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","article-title":"Prevalence and factors associated with multidrug-resistant tuberculosis in South India","volume":"10","author":"Shivekar","year":"2020","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12931-019-1199-3","article-title":"Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018","volume":"20","author":"Song","year":"2019","journal-title":"Respir. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2002328","DOI":"10.1183\/13993003.02328-2020","article-title":"On tuberculosis and COVID-19 co-infection","volume":"56","author":"Tadolini","year":"2020","journal-title":"Eur. Respir. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5588\/ijtld.23.0014","article-title":"Targeted TB control in migrants to low-burden countries","volume":"27","author":"Trauer","year":"2023","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12960-019-0420-2","article-title":"Transforming tuberculosis (TB) service delivery model in China: Issues and challenges for health workforce","volume":"17","author":"Wang","year":"2019","journal-title":"Hum. Resour. Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e059254","DOI":"10.1136\/bmjopen-2021-059254","article-title":"Epidemiology and control of diabetes - tuberculosis comorbidity in eswatini: Protocol for the prospective study of tuberculosis patients on predictive factors, treatment outcomes and patient management practices","volume":"12","author":"Williams","year":"2022","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e30405","DOI":"10.1097\/MD.0000000000030405","article-title":"Diagnosis and treatment of tuberculosis in adults with HIV","volume":"101","author":"Yang","year":"2022","journal-title":"Med. Baltim."},{"key":"B43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ajic.2015.12.042","article-title":"Status of drug-resistant tuberculosis in China: A systematic review and meta-analysis","volume":"44","author":"Zhang","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"B44","doi-asserted-by":"publisher","first-page":"300060520984932","DOI":"10.1177\/0300060520984932","article-title":"Analysis of drug resistance and mutation profiles in Mycobacterium tuberculosis isolates in a surveillance site in Beijing, China","volume":"49","author":"Zhang","year":"2021","journal-title":"J. Int. Med. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1263726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T01:36:33Z","timestamp":1695692193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1263726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":44,"alternative-id":["10.3389\/fphar.2023.1263726"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1263726","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"article-number":"1263726"}}